CYP7A1 Human (+)-schisandrin B multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP7A1 mRNA] CTD PMID:31150632 CYP7A1 Human (-)-epigallocatechin 3-gallate increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 epigallocatechin gallate results in increased expression of CYP7A1 mRNA and epigallocatechin gallate results in increased expression of CYP7A1 protein CTD PMID:23146761 CYP7A1 Human (1->4)-beta-D-glucan multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CYP7A1 mRNA CTD PMID:36331819 CYP7A1 Human (24S)-24-hydroxycholesterol increases metabolic processing EXP 6480464 CYP7A1 protein results in increased metabolism of 24-hydroxycholesterol CTD PMID:11013305 CYP7A1 Human (25R)-cholest-5-ene-3beta,26-diol increases metabolic processing ISO Cyp7a1 (Rattus norvegicus) 6480464 CYP7A1 protein results in increased metabolism of 27-hydroxycholesterol CTD PMID:10882719 CYP7A1 Human (25R)-cholest-5-ene-3beta,26-diol increases metabolic processing EXP 6480464 CYP7A1 protein results in increased metabolism of 27-hydroxycholesterol CTD PMID:10882719 CYP7A1 Human (E)-thiamethoxam decreases expression EXP 6480464 Thiamethoxam results in decreased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO Cyp7a1 (Mus musculus) 6480464 o and p'-DDT affects the expression of CYP7A1 mRNA CTD PMID:18925944 CYP7A1 Human 1,2-dichloroethane decreases expression ISO Cyp7a1 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of CYP7A1 mRNA CTD PMID:28189721 and PMID:28960355 CYP7A1 Human 1,3,7,9-tetramethyluric acid multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 1 more ... CTD PMID:35872049 CYP7A1 Human 1,4-dithiothreitol increases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Dithiothreitol results in increased activity of CYP7A1 protein CTD PMID:1175606 CYP7A1 Human 1-naphthyl isothiocyanate decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA and 1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein CTD PMID:14623915 more ... CYP7A1 Human 1-naphthyl isothiocyanate increases expression ISO Cyp7a1 (Mus musculus) 6480464 1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein CTD PMID:36787806 CYP7A1 Human 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein CTD PMID:36581201 CYP7A1 Human 1-naphthyl isothiocyanate multiple interactions EXP 6480464 4-methyl-7 and 8-dihydroxycoumarin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein] CTD PMID:36581201 CYP7A1 Human 1-naphthyl isothiocyanate decreases expression ISO Cyp7a1 (Rattus norvegicus) 15090803 1-naphthyl isothiocyanate decreases expression of Cyp7a1 protein in rat liver RGD CYP7A1 Human 1-naphthyl isothiocyanate increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of CYP7A1 mRNA CTD PMID:20551477 more ... CYP7A1 Human 1-naphthyl isothiocyanate decreases expression ISO Cyp7a1 (Mus musculus) 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA and 1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein CTD PMID:25655198 more ... CYP7A1 Human 1-naphthyl isothiocyanate multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] more ... CTD PMID:25655198 more ... CYP7A1 Human 1-naphthyl isothiocyanate multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] and resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein] CTD PMID:25418378 CYP7A1 Human 17alpha-ethynylestradiol multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Ethinyl Estradiol co-treated with Metformin] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:16606610 more ... CYP7A1 Human 17alpha-ethynylestradiol decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased activity of CYP7A1 protein CTD PMID:11473529 and PMID:9869655 CYP7A1 Human 17alpha-ethynylestradiol decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of CYP7A1 mRNA CTD PMID:16487557 more ... CYP7A1 Human 17alpha-ethynylestradiol multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 3 more ... CTD PMID:12963437 and PMID:16487557 CYP7A1 Human 17alpha-ethynylestradiol decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Ethinyl Estradiol results in decreased expression of CYP7A1 mRNA and Ethinyl Estradiol results in decreased expression of CYP7A1 protein CTD PMID:16606610 more ... CYP7A1 Human 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CYP7A1 mRNA CTD PMID:20106945 CYP7A1 Human 17beta-estradiol increases expression ISO Cyp7a1 (Mus musculus) 6480464 Estradiol results in increased expression of CYP7A1 mRNA and Estradiol results in increased expression of CYP7A1 protein CTD PMID:35802278 CYP7A1 Human 17beta-estradiol decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Estradiol results in decreased expression of CYP7A1 mRNA CTD PMID:32145629 CYP7A1 Human 1H-pyrazole decreases expression ISO Cyp7a1 (Mus musculus) 6480464 pyrazole results in decreased expression of CYP7A1 mRNA CTD PMID:17945193 CYP7A1 Human 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:23756648 more ... CYP7A1 Human 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 2 more ... CTD PMID:20056577 and PMID:27291303 CYP7A1 Human 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO Cyp7a1 (Mus musculus) 6480464 2 more ... CTD PMID:30294300 and PMID:33078840 CYP7A1 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP7A1 mRNA CTD PMID:20106945 CYP7A1 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP7A1 mRNA CTD PMID:32109520 CYP7A1 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:23756648 more ... CYP7A1 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CYP7A1 mRNA CTD PMID:26159488 CYP7A1 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP7A1 mRNA CTD PMID:16054898 and PMID:21215274 CYP7A1 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP7A1 mRNA CTD PMID:19770486 more ... CYP7A1 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cyp7a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP7A1 mRNA CTD PMID:21095216 CYP7A1 Human 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO Cyp7a1 (Mus musculus) 6480464 2 more ... CTD PMID:25768209 CYP7A1 Human 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 2 more ... CTD PMID:32109520 CYP7A1 Human 2,4,6-trinitrotoluene affects expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Trinitrotoluene affects the expression of CYP7A1 mRNA CTD PMID:21346803 CYP7A1 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Cyp7a1 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 CYP7A1 Human 2,4-dinitrotoluene affects expression ISO Cyp7a1 (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of CYP7A1 mRNA CTD PMID:21346803 CYP7A1 Human 2-acetamidofluorene multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP7A1 mRNA and [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CYP7A1 mRNA CTD PMID:14656948 and PMID:16158176 CYP7A1 Human 2-arachidonoylglycerol multiple interactions EXP 6480464 CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA] more ... CTD PMID:23894352 CYP7A1 Human 2-arachidonoylglycerol increases expression EXP 6480464 glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA CTD PMID:23894352 CYP7A1 Human 2-arachidonoylglycerol increases expression ISO Cyp7a1 (Mus musculus) 6480464 glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA CTD PMID:23894352 and PMID:28095641 CYP7A1 Human 2-arachidonoylglycerol multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA] CTD PMID:23894352 CYP7A1 Human 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 geranylgeranyl pyrophosphate inhibits the reaction [resveratrol results in increased expression of CYP7A1 mRNA] CTD PMID:22607622 CYP7A1 Human 20-hydroxycholesterol increases metabolic processing ISO Cyp7a1 (Rattus norvegicus) 6480464 CYP7A1 protein results in increased metabolism of 20-hydroxycholesterol CTD PMID:10882719 CYP7A1 Human 20-hydroxycholesterol increases metabolic processing EXP 6480464 CYP7A1 protein results in increased metabolism of 20-hydroxycholesterol CTD PMID:10882719 CYP7A1 Human 25-hydroxycholesterol increases metabolic processing EXP 6480464 CYP7A1 protein results in increased metabolism of 25-hydroxycholesterol CTD PMID:10882719 CYP7A1 Human 25-hydroxycholesterol increases metabolic processing ISO Cyp7a1 (Rattus norvegicus) 6480464 CYP7A1 protein results in increased metabolism of 25-hydroxycholesterol CTD PMID:10882719 CYP7A1 Human 26-hydroxycholesterol increases metabolic processing EXP 6480464 CYP7A1 protein results in increased metabolism of 27-hydroxycholesterol CTD PMID:10882719 CYP7A1 Human 26-hydroxycholesterol increases metabolic processing ISO Cyp7a1 (Rattus norvegicus) 6480464 CYP7A1 protein results in increased metabolism of 27-hydroxycholesterol CTD PMID:10882719 CYP7A1 Human 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23146750 CYP7A1 Human 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 3 more ... CTD PMID:19467301 CYP7A1 Human 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-decanol affects expression ISO Cyp7a1 (Rattus norvegicus) 6480464 fluorotelomer alcohols affects the expression of CYP7A1 mRNA CTD PMID:38903859 CYP7A1 Human 3-phenylprop-2-enal increases expression EXP 6480464 cinnamaldehyde results in increased expression of CYP7A1 mRNA CTD PMID:19000754 CYP7A1 Human 4,4'-sulfonyldiphenol decreases methylation ISO Cyp7a1 (Mus musculus) 6480464 bisphenol S results in decreased methylation of CYP7A1 exon CTD PMID:33297965 CYP7A1 Human 4,4'-sulfonyldiphenol affects methylation ISO Cyp7a1 (Mus musculus) 6480464 bisphenol S affects the methylation of CYP7A1 gene CTD PMID:31683443 CYP7A1 Human 7,9-dihydro-1H-purine-2,6,8(3H)-trione multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [1-Naphthylisothiocyanate co-treated with Uric Acid] results in decreased expression of CYP7A1 mRNA CTD PMID:33749747 CYP7A1 Human 7-ketocholesterol decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 7-ketocholesterol results in decreased activity of CYP7A1 protein CTD PMID:1175606 CYP7A1 Human 7alpha-hydroxycholesterol multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Uranyl Nitrate results in decreased activity of CYP7A1 protein] which results in decreased chemical synthesis of cholest-5-en-3 beta and 7 alpha-diol CTD PMID:20362056 CYP7A1 Human 8-Epidiosbulbin E acetate decreases expression ISO Cyp7a1 (Mus musculus) 6480464 8-epidiosbulbin E acetate results in decreased expression of CYP7A1 mRNA and 8-epidiosbulbin E acetate results in decreased expression of CYP7A1 protein CTD PMID:31626840 CYP7A1 Human acrylamide increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Acrylamide results in increased expression of CYP7A1 mRNA CTD PMID:15749267 CYP7A1 Human acrylamide multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 Acrylamide inhibits the reaction [Streptozocin results in increased expression of CYP7A1 mRNA] CTD PMID:34896238 CYP7A1 Human acrylamide decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Acrylamide results in decreased expression of CYP7A1 mRNA CTD PMID:34896238 CYP7A1 Human Actein increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 actein results in increased expression of CYP7A1 mRNA CTD PMID:19527300 CYP7A1 Human aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of CYP7A1 protein CTD PMID:20106945 CYP7A1 Human aflatoxin B1 multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 fexaramine inhibits the reaction [Aflatoxin B1 results in increased expression of CYP7A1 mRNA] CTD PMID:37030333 CYP7A1 Human aflatoxin B1 increases expression ISO Cyp7a1 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of CYP7A1 mRNA and Aflatoxin B1 results in increased expression of CYP7A1 protein CTD PMID:37030333 CYP7A1 Human aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CYP7A1 mRNA CTD PMID:22100608 and PMID:27153756 CYP7A1 Human aflatoxin B1 decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of CYP7A1 mRNA CTD PMID:19770486 CYP7A1 Human alfacalcidol increases expression ISO Cyp7a1 (Mus musculus) 6480464 alfacalcidol results in increased expression of CYP7A1 mRNA CTD PMID:19581390 CYP7A1 Human all-trans-retinoic acid multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tretinoin results in decreased expression of CYP7A1 mRNA] more ... CTD PMID:21274875 and PMID:30709899 CYP7A1 Human all-trans-retinoic acid increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Tretinoin results in increased expression of CYP7A1 mRNA CTD PMID:24977338 CYP7A1 Human all-trans-retinoic acid multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Tretinoin co-treated with Ursodeoxycholic Acid] results in decreased expression of CYP7A1 mRNA CTD PMID:21274875 CYP7A1 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of CYP7A1 mRNA and Tretinoin results in decreased expression of CYP7A1 protein CTD PMID:21274875 and PMID:30709899 CYP7A1 Human allopurinol multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [1-Naphthylisothiocyanate co-treated with Allopurinol] results in decreased expression of CYP7A1 mRNA CTD PMID:33749747 CYP7A1 Human AM-251 multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 AM 251 inhibits the reaction [Ethanol results in increased expression of CYP7A1 mRNA] CTD PMID:23894352 and PMID:28095641 CYP7A1 Human amiodarone decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Amiodarone results in decreased expression of CYP7A1 mRNA CTD PMID:19224547 CYP7A1 Human amiodarone increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Amiodarone results in increased expression of CYP7A1 mRNA CTD PMID:22291062 CYP7A1 Human ammonium chloride affects expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of CYP7A1 mRNA CTD PMID:16483693 CYP7A1 Human amphibole asbestos affects expression EXP 6480464 Asbestos and Amphibole affects the expression of CYP7A1 protein CTD PMID:20855422 CYP7A1 Human amphotericin B multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] and [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA CTD PMID:36464106 CYP7A1 Human ampicillin multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] more ... CTD PMID:36464106 and PMID:37211107 CYP7A1 Human angelicin decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 angelicin results in decreased expression of CYP7A1 mRNA and angelicin results in decreased expression of CYP7A1 protein CTD PMID:30597224 CYP7A1 Human anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Tretinoin results in decreased expression of CYP7A1 mRNA] and pyrazolanthrone inhibits the reaction [Tretinoin results in decreased expression of CYP7A1 protein] CTD PMID:30709899 CYP7A1 Human arsane multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [APOE protein affects the susceptibility to Arsenic] which affects the expression of CYP7A1 mRNA CTD PMID:22719926 CYP7A1 Human arsenic atom multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [APOE protein affects the susceptibility to Arsenic] which affects the expression of CYP7A1 mRNA CTD PMID:22719926 CYP7A1 Human atazanavir sulfate multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA CTD PMID:32152650 CYP7A1 Human atazanavir sulfate decreases expression EXP 6480464 Atazanavir Sulfate results in decreased expression of CYP7A1 mRNA CTD PMID:32152650 CYP7A1 Human atorvastatin calcium increases expression ISO Cyp7a1 (Mus musculus) 6480464 Atorvastatin results in increased expression of CYP7A1 mRNA CTD PMID:25278499 CYP7A1 Human atorvastatin calcium multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 Atorvastatin inhibits the reaction [Dietary Fats results in decreased expression of CYP7A1 mRNA] CTD PMID:32048413 CYP7A1 Human atrazine increases expression ISO Cyp7a1 (Mus musculus) 6480464 Atrazine results in increased expression of CYP7A1 mRNA CTD PMID:22515965 CYP7A1 Human Augmentin decreases expression EXP 6480464 Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP7A1 mRNA CTD PMID:34767876 CYP7A1 Human azoxystrobin decreases expression EXP 6480464 azoxystrobin results in decreased expression of CYP7A1 mRNA and azoxystrobin results in decreased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human Benoxacor increases expression ISO Cyp7a1 (Mus musculus) 6480464 benoxacor results in increased expression of CYP7A1 mRNA CTD PMID:34850242 CYP7A1 Human benzo[a]pyrene decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of CYP7A1 mRNA CTD PMID:19770486 CYP7A1 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CYP7A1 mRNA CTD PMID:32234424 CYP7A1 Human benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of CYP7A1 promoter CTD PMID:27901495 CYP7A1 Human benzo[a]pyrene multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [corannulene co-treated with Benzo(a)pyrene] results in increased expression of CYP7A1 mRNA CTD PMID:32417428 CYP7A1 Human benzo[a]pyrene affects expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Benzo(a)pyrene affects the expression of CYP7A1 mRNA CTD PMID:22374506 CYP7A1 Human Benzo[b]fluorene affects expression ISO Cyp7a1 (Rattus norvegicus) 6480464 benzo(b)fluorene affects the expression of CYP7A1 mRNA CTD PMID:38903859 CYP7A1 Human beta-hexachlorocyclohexane increases expression ISO Cyp7a1 (Mus musculus) 6480464 beta-hexachlorocyclohexane results in increased expression of CYP7A1 mRNA CTD PMID:28392238 CYP7A1 Human beta-hexachlorocyclohexane increases expression EXP 6480464 beta-hexachlorocyclohexane results in increased expression of CYP7A1 mRNA CTD PMID:28392238 CYP7A1 Human beta-naphthoflavone decreases expression EXP 6480464 beta-Naphthoflavone results in decreased expression of CYP7A1 mRNA CTD PMID:22258563 CYP7A1 Human bezafibrate decreases activity EXP 6480464 Bezafibrate results in decreased activity of CYP7A1 protein CTD PMID:2044640 CYP7A1 Human bezafibrate decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Bezafibrate results in decreased activity of CYP7A1 protein CTD PMID:2044640 CYP7A1 Human bezafibrate decreases expression EXP 6480464 Bezafibrate results in decreased expression of CYP7A1 mRNA CTD PMID:14685799 CYP7A1 Human bilirubin IXalpha multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Manganese co-treated with Bilirubin] results in decreased activity of CYP7A1 protein CTD PMID:12700418 CYP7A1 Human bilirubin IXalpha decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Bilirubin results in decreased activity of CYP7A1 protein CTD PMID:12700418 CYP7A1 Human bis(2-ethylhexyl) phthalate increases expression ISO Cyp7a1 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of CYP7A1 mRNA CTD PMID:19850644 CYP7A1 Human bis(2-ethylhexyl) phthalate increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Diethylhexyl Phthalate results in increased expression of CYP7A1 mRNA CTD PMID:29945229 and PMID:35970509 CYP7A1 Human bis(2-ethylhexyl) phthalate multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [APOE gene mutant form results in increased susceptibility to Diethylhexyl Phthalate] which results in decreased expression of CYP7A1 protein more ... CTD PMID:19850644 more ... CYP7A1 Human bisphenol A increases expression ISO Cyp7a1 (Mus musculus) 6480464 bisphenol A results in increased expression of CYP7A1 mRNA and bisphenol A results in increased expression of CYP7A1 protein CTD PMID:17706920 more ... CYP7A1 Human bisphenol A decreases expression ISO Cyp7a1 (Mus musculus) 6480464 bisphenol A results in decreased expression of CYP7A1 mRNA CTD PMID:32156529 CYP7A1 Human bisphenol A affects expression ISO Cyp7a1 (Rattus norvegicus) 6480464 bisphenol A affects the expression of CYP7A1 mRNA CTD PMID:30903817 CYP7A1 Human bisphenol A decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of CYP7A1 mRNA CTD PMID:25181051 more ... CYP7A1 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP7A1 mRNA CTD PMID:23146750 CYP7A1 Human bisphenol A multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:17706920 more ... CYP7A1 Human bosentan decreases expression EXP 6480464 Bosentan results in decreased expression of CYP7A1 mRNA CTD PMID:29761207 CYP7A1 Human bromobenzene increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 bromobenzene results in increased expression of CYP7A1 mRNA CTD PMID:32479839 CYP7A1 Human cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYP7A1 mRNA CTD PMID:35301059 CYP7A1 Human cadmium dichloride decreases methylation ISO Cyp7a1 (Rattus norvegicus) 6480464 Cadmium Chloride results in decreased methylation of CYP7A1 promoter CTD PMID:22457795 CYP7A1 Human cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYP7A1 mRNA CTD PMID:35301059 CYP7A1 Human calcipotriol multiple interactions EXP 6480464 calcipotriene inhibits the reaction [VDR protein affects the expression of CYP7A1 protein] CTD PMID:30419252 CYP7A1 Human calcipotriol decreases expression EXP 6480464 calcipotriene results in decreased expression of CYP7A1 protein CTD PMID:30419252 CYP7A1 Human calcitriol multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in decreased expression of CYP7A1 mRNA] more ... CTD PMID:19106115 and PMID:20371703 CYP7A1 Human calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of CYP7A1 mRNA CTD PMID:20371703 CYP7A1 Human carbendazim decreases expression EXP 6480464 carbendazim results in decreased expression of CYP7A1 mRNA and carbendazim results in decreased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human carbon nanotube affects expression ISO Cyp7a1 (Mus musculus) 6480464 Nanotubes and Carbon analog affects the expression of CYP7A1 mRNA CTD PMID:25620056 CYP7A1 Human carbon nanotube decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of CYP7A1 mRNA CTD PMID:25620056 CYP7A1 Human carnosic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 salvin inhibits the reaction [sodium arsenite results in decreased expression of CYP7A1 mRNA] CTD PMID:35202923 CYP7A1 Human carvedilol increases expression ISO Cyp7a1 (Mus musculus) 6480464 Carvedilol results in increased expression of CYP7A1 protein CTD PMID:37632784 CYP7A1 Human chenodeoxycholic acid decreases expression EXP 6480464 Chenodeoxycholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:19072826 more ... CYP7A1 Human chenodeoxycholic acid decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Chenodeoxycholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:19072826 more ... CYP7A1 Human chenodeoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:17963371 more ... CYP7A1 Human chenodeoxycholic acid multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Chenodeoxycholic Acid co-treated with Ketoconazole] results in decreased expression of CYP7A1 mRNA and [Chenodeoxycholic Acid results in increased expression of FGF19 protein] which results in decreased expression of CYP7A1 protein CTD PMID:20835427 and PMID:30985903 CYP7A1 Human chenodeoxycholic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of CYP7A1 mRNA] more ... CTD PMID:19072826 more ... CYP7A1 Human chitosan multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 Chitosan inhibits the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA] and Fish Oils promotes the reaction [Chitosan inhibits the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA]] CTD PMID:28987369 CYP7A1 Human chlormequat chloride increases expression EXP 6480464 Chlormequat results in increased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human chloroquine multiple interactions EXP 6480464 Chloroquine promotes the reaction [CYP7A1 protein results in increased expression of MAP1LC3B protein modified form] and CYP7A1 mRNA promotes the reaction [Chloroquine results in increased expression of MAP1LC3B protein modified form] CTD PMID:28275691 CYP7A1 Human chlorpyrifos increases expression ISO Cyp7a1 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of CYP7A1 mRNA CTD PMID:32715474 CYP7A1 Human chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of CYP7A1 mRNA and Chlorpyrifos results in decreased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human cholate decreases expression EXP 6480464 Cholates results in decreased expression of CYP7A1 mRNA CTD PMID:14684751 CYP7A1 Human cholate decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Cholates results in decreased expression of CYP7A1 CTD PMID:10809780 CYP7A1 Human cholesta-5,7-dien-3beta-ol decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 7-dehydrocholesterol results in decreased activity of CYP7A1 protein CTD PMID:1175606 CYP7A1 Human cholesterol affects metabolic processing EXP 6480464 CYP7A1 protein affects the metabolism of Cholesterol CTD PMID:15696852 CYP7A1 Human cholesterol multiple interactions EXP 6480464 CYP7A1 mRNA inhibits the reaction [Cholesterol results in increased phosphorylation of EIF4EBP1 protein] more ... CTD PMID:28275691 and PMID:30709899 CYP7A1 Human cholesterol increases metabolic processing ISO Cyp7a1 (Rattus norvegicus) 6480464 CYP7A1 protein results in increased metabolism of Cholesterol CTD PMID:1175606 CYP7A1 Human cholesterol increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Cholesterol results in increased expression of CYP7A1 mRNA CTD PMID:21535835 CYP7A1 Human cholesterol multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 turmeric extract promotes the reaction [Cholesterol results in increased expression of CYP7A1 mRNA] CTD PMID:21535835 CYP7A1 Human cholesterol increases metabolic processing EXP 6480464 CYP7A1 protein results in increased metabolism of Cholesterol CTD PMID:11013305 and PMID:7925343 CYP7A1 Human cholic acid decreases expression EXP 6480464 Cholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:25055961 CYP7A1 Human cholic acid decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Cholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:12072388 more ... CYP7A1 Human cholic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Cholic Acid binds to and results in increased activity of NR1H4 protein] which results in decreased expression of CYP7A1 mRNA CTD PMID:22540009 CYP7A1 Human cholic acid multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Cholesterol more ... CTD PMID:14684380 CYP7A1 Human chrysophanol increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 chrysophanic acid results in increased expression of CYP7A1 mRNA and chrysophanic acid results in increased expression of CYP7A1 protein CTD PMID:28161596 CYP7A1 Human ciguatoxin CTX1B affects expression ISO Cyp7a1 (Mus musculus) 6480464 Ciguatoxins affects the expression of CYP7A1 mRNA CTD PMID:18353800 CYP7A1 Human clavulanic acid decreases expression EXP 6480464 Clavulanic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:34767876 CYP7A1 Human clofibrate decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Clofibrate results in decreased expression of CYP7A1 mRNA CTD PMID:17585979 CYP7A1 Human clofibrate decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Clofibrate results in decreased expression of CYP7A1 mRNA CTD PMID:19224547 CYP7A1 Human clofibrate increases expression ISO Cyp7a1 (Mus musculus) 6480464 Clofibrate results in increased expression of CYP7A1 mRNA CTD PMID:28973556 CYP7A1 Human clothianidin decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 clothianidin results in decreased expression of CYP7A1 mRNA CTD PMID:33426623 CYP7A1 Human clothianidin multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [enilconazole co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA and [thiacloprid co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA CTD PMID:33426623 CYP7A1 Human cobalt atom increases expression ISO Cyp7a1 (Mus musculus) 6480464 Cobalt results in increased expression of CYP7A1 mRNA CTD PMID:22147119 CYP7A1 Human copper atom decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Copper results in decreased expression of CYP7A1 mRNA CTD PMID:17205981 CYP7A1 Human copper atom decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Copper results in decreased activity of CYP7A1 protein CTD PMID:1175606 CYP7A1 Human copper atom increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Copper deficiency results in increased expression of CYP7A1 mRNA CTD PMID:11110846 CYP7A1 Human copper(0) decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Copper results in decreased expression of CYP7A1 mRNA CTD PMID:17205981 CYP7A1 Human copper(0) decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Copper results in decreased activity of CYP7A1 protein CTD PMID:1175606 CYP7A1 Human copper(0) increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Copper deficiency results in increased expression of CYP7A1 mRNA CTD PMID:11110846 CYP7A1 Human copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of CYP7A1 mRNA CTD PMID:19549813 CYP7A1 Human cordycepin increases expression EXP 6480464 cordycepin results in increased expression of CYP7A1 mRNA CTD PMID:24286368 CYP7A1 Human corn oil affects expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Corn Oil affects the expression of CYP7A1 mRNA CTD PMID:16360708 CYP7A1 Human coumarin decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 coumarin results in decreased expression of CYP7A1 mRNA CTD PMID:18480146 CYP7A1 Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of CYP7A1 mRNA and Cyclosporine results in decreased expression of CYP7A1 protein CTD PMID:20106945 more ... CYP7A1 Human cyclosporin A multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA and [Cyclosporine results in decreased expression of CYP7A1 protein] which affects the abundance of Cholic Acids CTD PMID:26198044 and PMID:32152650 CYP7A1 Human cyclosporin A increases expression ISO Cyp7a1 (Mus musculus) 6480464 Cyclosporine results in increased expression of CYP7A1 mRNA CTD PMID:19770486 CYP7A1 Human cyproconazole multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP7A1 mRNA CTD PMID:29038839 CYP7A1 Human cyproconazole decreases expression EXP 6480464 cyproconazole results in decreased expression of CYP7A1 mRNA CTD PMID:29995386 CYP7A1 Human cyprodinil decreases expression EXP 6480464 cyprodinil results in decreased expression of CYP7A1 mRNA and cyprodinil results in decreased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human cysteamine increases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Cysteamine results in increased activity of CYP7A1 protein CTD PMID:1175606 CYP7A1 Human DDE increases expression ISO Cyp7a1 (Mus musculus) 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CYP7A1 mRNA CTD PMID:28392238 CYP7A1 Human DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CYP7A1 mRNA CTD PMID:28392238 CYP7A1 Human deoxycholic acid decreases expression EXP 6480464 Deoxycholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:14684751 and PMID:25055961 CYP7A1 Human deoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:32152650 and PMID:33819548 CYP7A1 Human deoxycholic acid decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Deoxycholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:20671298 more ... CYP7A1 Human deoxycholic acid decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Deoxycholic Acid results in decreased activity of CYP7A1 protein CTD PMID:1175606 CYP7A1 Human deoxycholic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Deoxycholic Acid results in increased activity of NR1H4 protein] which results in increased expression of CYP7A1 mRNA and SLCO1A1 protein affects the susceptibility to [Deoxycholic Acid results in decreased expression of CYP7A1 mRNA] CTD PMID:21914718 and PMID:22531947 CYP7A1 Human dexamethasone increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Dexamethasone results in increased expression of CYP7A1 mRNA CTD PMID:15965953 and PMID:32599024 CYP7A1 Human dexamethasone decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Dexamethasone results in decreased expression of CYP7A1 mRNA CTD PMID:20888898 CYP7A1 Human dextran sulfate decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Dextran Sulfate results in decreased expression of CYP7A1 mRNA CTD PMID:27580383 CYP7A1 Human diallyl trisulfide decreases expression EXP 6480464 diallyl trisulfide results in decreased expression of CYP7A1 mRNA CTD PMID:16382202 CYP7A1 Human dichloroacetic acid increases expression ISO Cyp7a1 (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of CYP7A1 mRNA CTD PMID:28962523 and PMID:34850242 CYP7A1 Human diclofenac increases expression ISO Cyp7a1 (Mus musculus) 6480464 Diclofenac results in increased expression of CYP7A1 mRNA CTD PMID:26934552 CYP7A1 Human dicrotophos decreases expression EXP 6480464 dicrotophos results in decreased expression of CYP7A1 mRNA CTD PMID:28302478 CYP7A1 Human difenoconazole decreases expression EXP 6480464 difenoconazole results in decreased expression of CYP7A1 mRNA and difenoconazole results in decreased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human dihydroartemisinin multiple interactions ISO Cyp7a1 (Rattus norvegicus) 15036816 Dihydroartemisinin inhibits the reaction [ethanol increases expression of Cyp7a1 protein in liver] RGD CYP7A1 Human dihydroxyacetone decreases expression EXP 6480464 Dihydroxyacetone results in decreased expression of CYP7A1 mRNA CTD PMID:32506039 CYP7A1 Human Diisodecyl phthalate increases expression ISO Cyp7a1 (Mus musculus) 6480464 diisodecyl phthalate results in increased expression of CYP7A1 mRNA CTD PMID:25270620 CYP7A1 Human dimethomorph decreases expression EXP 6480464 dimethomorph results in decreased expression of CYP7A1 mRNA and dimethomorph results in decreased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human dimethyl sulfoxide increases expression ISO Cyp7a1 (Rattus norvegicus) 15092090 DMSO increases expression of Cyp7a1 mRNA in rat liver and reaction inhibited by INT-767 RGD CYP7A1 Human Diosbulbin B decreases activity ISO Cyp7a1 (Mus musculus) 6480464 diosbulbin B results in decreased activity of CYP7A1 protein CTD PMID:32148032 CYP7A1 Human Diosbulbin B increases expression EXP 6480464 diosbulbin B results in increased expression of CYP7A1 mRNA CTD PMID:39368342 CYP7A1 Human Diosbulbin B decreases expression ISO Cyp7a1 (Mus musculus) 6480464 diosbulbin B results in decreased expression of CYP7A1 mRNA CTD PMID:32148032 and PMID:39368342 CYP7A1 Human diosgenin multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Ethinyl Estradiol co-treated with Diosgenin] results in increased expression of CYP7A1 mRNA more ... CTD PMID:12963437 and PMID:33383043 CYP7A1 Human dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of CYP7A1 mRNA CTD PMID:19695866 CYP7A1 Human disodium selenite multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] CTD PMID:36464106 CYP7A1 Human elemental selenium multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Magnesium co-treated with Selenium co-treated with Dietary Fats] results in increased expression of CYP7A1 mRNA CTD PMID:30031400 CYP7A1 Human elemental selenium multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] CTD PMID:36464106 CYP7A1 Human emodin decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Emodin results in decreased expression of CYP7A1 mRNA and Emodin results in decreased expression of CYP7A1 protein CTD PMID:28161596 CYP7A1 Human emodin multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [2 more ... CTD PMID:35753641 CYP7A1 Human endosulfan multiple interactions EXP 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CYP7A1 mRNA CTD PMID:26159488 CYP7A1 Human endosulfan decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of CYP7A1 mRNA CTD PMID:29391264 CYP7A1 Human endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CYP7A1 mRNA CTD PMID:26159488 CYP7A1 Human enilconazole decreases expression ISO Cyp7a1 (Mus musculus) 6480464 enilconazole results in decreased expression of CYP7A1 mRNA CTD PMID:29451352 and PMID:32814239 CYP7A1 Human enilconazole decreases expression EXP 6480464 enilconazole results in decreased expression of CYP7A1 mRNA and enilconazole results in decreased expression of CYP7A1 protein CTD PMID:32194361 and PMID:32201337 CYP7A1 Human enilconazole multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [enilconazole co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA and [thiacloprid co-treated with enilconazole] results in decreased expression of CYP7A1 mRNA CTD PMID:33426623 CYP7A1 Human Epomediol increases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 epomediol results in increased activity of CYP7A1 protein CTD PMID:10961725 and PMID:11473529 CYP7A1 Human Epomediol increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 epomediol results in increased expression of CYP7A1 mRNA CTD PMID:11473529 CYP7A1 Human epoxiconazole multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP7A1 mRNA CTD PMID:29038839 CYP7A1 Human epoxiconazole decreases expression ISO Cyp7a1 (Mus musculus) 6480464 epoxiconazole results in decreased expression of CYP7A1 mRNA CTD PMID:35436446 CYP7A1 Human epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of CYP7A1 mRNA CTD PMID:32194361 CYP7A1 Human ethambutol multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of CYP7A1 protein CTD PMID:35835356 CYP7A1 Human ethambutol multiple interactions EXP 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of CYP7A1 protein CTD PMID:35835356 CYP7A1 Human ethanol multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 1 more ... CTD PMID:17347304 and PMID:35872049 CYP7A1 Human ethanol increases expression ISO Cyp7a1 (Rattus norvegicus) 15036816 ethanol increases expression of Cyp7a1 protein in liver RGD CYP7A1 Human ethanol increases expression ISO Cyp7a1 (Mus musculus) 6480464 Ethanol results in increased expression of CYP7A1 mRNA and Ethanol results in increased expression of CYP7A1 protein CTD PMID:19167417 more ... CYP7A1 Human ethanol multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 AM 251 inhibits the reaction [Ethanol results in increased expression of CYP7A1 mRNA] more ... CTD PMID:23894352 and PMID:28095641 CYP7A1 Human ethoprophos decreases expression EXP 6480464 ethoprop results in decreased expression of CYP7A1 mRNA and ethoprop results in decreased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human fenbuconazole decreases expression EXP 6480464 fenbuconazole results in decreased expression of CYP7A1 mRNA CTD PMID:15942997 CYP7A1 Human fenhexamid decreases expression EXP 6480464 N-(2 and 3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in decreased expression of CYP7A1 mRNA CTD PMID:32194361 CYP7A1 Human fenofibrate multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP7A1 mRNA CTD PMID:18253720 CYP7A1 Human fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of CYP7A1 mRNA CTD PMID:14685799 CYP7A1 Human fenpyroximate decreases expression EXP 6480464 fenpyroximate results in decreased expression of CYP7A1 mRNA and fenpyroximate results in decreased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human fenvalerate decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 fenvalerate results in decreased expression of CYP7A1 mRNA CTD PMID:30307764 CYP7A1 Human Fexaramine multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 fexaramine inhibits the reaction [Aflatoxin B1 results in increased expression of CYP7A1 mRNA] CTD PMID:37030333 CYP7A1 Human fipronil decreases expression EXP 6480464 fipronil results in decreased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human fipronil increases expression EXP 6480464 fipronil results in increased expression of CYP7A1 mRNA CTD PMID:32194361 CYP7A1 Human fisetin multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 fisetin inhibits the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA] CTD PMID:23524313 CYP7A1 Human flavonoids increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Flavonoids results in increased expression of CYP7A1 mRNA CTD PMID:18035473 CYP7A1 Human fludioxonil decreases expression EXP 6480464 fludioxonil results in decreased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human flusilazole decreases expression EXP 6480464 flusilazole results in decreased expression of CYP7A1 mRNA CTD PMID:32194361 CYP7A1 Human flutamide decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Flutamide results in decreased expression of CYP7A1 mRNA CTD PMID:24136188 CYP7A1 Human fluxapyroxad decreases expression EXP 6480464 fluxapyroxad results in decreased expression of CYP7A1 mRNA and fluxapyroxad results in decreased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human furan decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 furan results in decreased expression of CYP7A1 mRNA CTD PMID:15120968 and PMID:38160780 CYP7A1 Human furan decreases expression ISO Cyp7a1 (Mus musculus) 6480464 furan results in decreased expression of CYP7A1 mRNA CTD PMID:32251705 CYP7A1 Human furan multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 rhodioloside inhibits the reaction [furan results in decreased expression of CYP7A1 mRNA] CTD PMID:32251705 CYP7A1 Human furan increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 furan results in increased expression of CYP7A1 mRNA CTD PMID:25539665 CYP7A1 Human gemfibrozil decreases expression EXP 6480464 Gemfibrozil results in decreased expression of CYP7A1 mRNA CTD PMID:14685799 CYP7A1 Human genistein multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of CYP7A1 mRNA CTD PMID:21782745 CYP7A1 Human Gentiopicrin decreases expression ISO Cyp7a1 (Rattus norvegicus) 15045612 Gentiopicrin decreases expression of Cyp7a1 mRNA in rat ANIT induced cholestatic liver RGD CYP7A1 Human glycochenodeoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:32152650 and PMID:33819548 CYP7A1 Human glycocholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:32152650 and PMID:33819548 CYP7A1 Human glycodeoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:32152650 and PMID:33819548 CYP7A1 Human glycyrrhetinate multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] CTD PMID:28549656 CYP7A1 Human glycyrrhetinic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] CTD PMID:28549656 CYP7A1 Human glycyrrhizinic acid decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Glycyrrhizic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:22982774 CYP7A1 Human glycyrrhizinic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 Glycyrrhizic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] CTD PMID:28549656 CYP7A1 Human gold atom increases expression EXP 6480464 Gold analog results in increased expression of CYP7A1 mRNA CTD PMID:36057382 CYP7A1 Human gold(0) increases expression EXP 6480464 Gold analog results in increased expression of CYP7A1 mRNA CTD PMID:36057382 CYP7A1 Human graphene oxide increases expression ISO Cyp7a1 (Mus musculus) 6480464 graphene oxide results in increased expression of CYP7A1 mRNA CTD PMID:33227293 CYP7A1 Human guggulsterone multiple interactions ISO Cyp7a1 (Rattus norvegicus) 15036816 Z-guggulsterone reverses the reaction [Dihydroartemisinin inhibits the reaction [ethanol increases expression of Cyp7a1 protein in liver]] RGD CYP7A1 Human guggulsterone multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 pregna-4 more ... CTD PMID:25655198 more ... CYP7A1 Human guggulsterone multiple interactions EXP 6480464 pregna-4 more ... CTD PMID:12705905 and PMID:35523117 CYP7A1 Human GW 3965 increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 GW 3965 results in increased expression of CYP7A1 mRNA CTD PMID:17420776 CYP7A1 Human GW 4064 decreases expression EXP 6480464 GW 4064 results in decreased expression of CYP7A1 mRNA CTD PMID:31437187 CYP7A1 Human GW 4064 decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 GW 4064 results in decreased expression of CYP7A1 mRNA CTD PMID:14623915 and PMID:15644430 CYP7A1 Human GW 4064 decreases expression ISO Cyp7a1 (Mus musculus) 6480464 GW 4064 results in decreased expression of CYP7A1 mRNA CTD PMID:27609522 and PMID:36511616 CYP7A1 Human GW 4064 multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [GW 4064 binds to and results in increased activity of NR1H4 protein] which results in decreased expression of CYP7A1 mRNA more ... CTD PMID:22467244 more ... CYP7A1 Human Heliotrine decreases expression EXP 6480464 heliotrine results in decreased expression of CYP7A1 mRNA CTD PMID:26100227 CYP7A1 Human hexadecanoic acid multiple interactions EXP 6480464 [Oleic Acid co-treated with Palmitic Acid] results in increased expression of CYP7A1 mRNA and Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CYP7A1 mRNA] CTD PMID:38103844 CYP7A1 Human hyperforin decreases expression EXP 6480464 hyperforin results in decreased expression of CYP7A1 mRNA CTD PMID:24259679 CYP7A1 Human icariside II increases expression ISO Cyp7a1 (Mus musculus) 6480464 baohuoside I results in increased expression of CYP7A1 mRNA and baohuoside I results in increased expression of CYP7A1 protein CTD PMID:35802278 CYP7A1 Human icariside II increases expression EXP 6480464 baohuoside I results in increased expression of CYP7A1 mRNA and baohuoside I results in increased expression of CYP7A1 protein CTD PMID:35802278 CYP7A1 Human imipenem hydrate multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Vancomycin co-treated with Imipenem] results in decreased expression of CYP7A1 mRNA CTD PMID:24657338 CYP7A1 Human indoxyl sulfate decreases expression EXP 6480464 Indican results in decreased expression of CYP7A1 mRNA CTD PMID:30639138 CYP7A1 Human iprodione decreases expression EXP 6480464 iprodione results in decreased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human isoniazide increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Isoniazid results in increased expression of CYP7A1 mRNA CTD PMID:25331106 and PMID:32673658 CYP7A1 Human isoniazide multiple interactions EXP 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of CYP7A1 protein and [Isoniazid co-treated with Vitamin B 6] results in increased expression of CYP7A1 mRNA CTD PMID:32673658 and PMID:35835356 CYP7A1 Human isoniazide multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of CYP7A1 protein more ... CTD PMID:25331106 more ... CYP7A1 Human kaempferol multiple interactions EXP 6480464 kaempferol analog inhibits the reaction [Acetaminophen results in increased expression of CYP7A1 mRNA] CTD PMID:36150480 CYP7A1 Human ketoconazole multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Chenodeoxycholic Acid co-treated with Ketoconazole] results in decreased expression of CYP7A1 mRNA CTD PMID:30985903 CYP7A1 Human ketoconazole increases expression ISO Cyp7a1 (Mus musculus) 6480464 Ketoconazole results in increased expression of CYP7A1 mRNA CTD PMID:31099283 CYP7A1 Human kojic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA and [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP7A1 mRNA CTD PMID:17917374 CYP7A1 Human L-1,4-dithiothreitol increases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Dithiothreitol results in increased activity of CYP7A1 protein CTD PMID:1175606 CYP7A1 Human L-ascorbic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA and [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA CTD PMID:17917374 CYP7A1 Human Lasiocarpine decreases expression EXP 6480464 lasiocarpine results in decreased expression of CYP7A1 mRNA CTD PMID:32234424 CYP7A1 Human lead nitrate decreases expression ISO Cyp7a1 (Mus musculus) 6480464 lead nitrate results in decreased expression of CYP7A1 mRNA CTD PMID:16049268 and PMID:22293356 CYP7A1 Human lead nitrate multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in decreased expression of CYP7A1 mRNA] CTD PMID:22293356 CYP7A1 Human lead nitrate decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 lead nitrate results in decreased expression of CYP7A1 mRNA CTD PMID:15475176 CYP7A1 Human lead(0) multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 puerarin affects the reaction [Lead affects the expression of CYP7A1] CTD PMID:22001170 CYP7A1 Human lead(0) decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Lead results in decreased activity of CYP7A1 protein CTD PMID:1175606 CYP7A1 Human lead(0) affects expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Lead affects the expression of CYP7A1 CTD PMID:22001170 CYP7A1 Human lipopolysaccharide multiple interactions EXP 6480464 [S-(1 more ... CTD PMID:22777745 and PMID:35811015 CYP7A1 Human lipopolysaccharide multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [triptolide co-treated with Lipopolysaccharides] results in decreased expression of CYP7A1 protein and obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in decreased expression of CYP7A1 protein] CTD PMID:36328986 CYP7A1 Human lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CYP7A1 mRNA CTD PMID:35811015 CYP7A1 Human lipopolysaccharide multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Lipopolysaccharides co-treated with Isoniazid] results in increased expression of CYP7A1 mRNA CTD PMID:25331106 CYP7A1 Human lipopolysaccharide increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Lipopolysaccharides results in increased expression of CYP7A1 mRNA CTD PMID:25331106 CYP7A1 Human lithocholic acid decreases expression EXP 6480464 Lithocholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:25055961 CYP7A1 Human lithocholic acid decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Lithocholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:16436656 more ... CYP7A1 Human lithocholic acid multiple interactions EXP 6480464 [Lithocholic Acid analog binds to and results in increased activity of NR1H4 protein] which results in decreased expression of CYP7A1 mRNA and [Lithocholic Acid binds to and results in increased activity of NR1H4 protein] which results in decreased expression of CYP7A1 mRNA CTD PMID:17963371 CYP7A1 Human lithocholic acid decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Lithocholic Acid results in decreased activity of CYP7A1 protein CTD PMID:1175606 CYP7A1 Human lithocholic acid decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Lithocholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:20888898 CYP7A1 Human lithocholic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 1 more ... CTD PMID:19196849 more ... CYP7A1 Human loperamide increases expression ISO Cyp7a1 (Mus musculus) 6480464 Loperamide results in increased expression of CYP7A1 mRNA CTD PMID:35926757 CYP7A1 Human magnesium atom multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Magnesium co-treated with Selenium co-treated with Dietary Fats] results in increased expression of CYP7A1 mRNA CTD PMID:30031400 CYP7A1 Human maneb decreases expression EXP 6480464 Maneb results in decreased expression of CYP7A1 mRNA CTD PMID:32194361 CYP7A1 Human manganese atom multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Manganese co-treated with Bilirubin] results in decreased activity of CYP7A1 protein CTD PMID:12700418 CYP7A1 Human manganese atom increases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Manganese results in increased activity of CYP7A1 protein CTD PMID:12700418 CYP7A1 Human manganese(0) multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Manganese co-treated with Bilirubin] results in decreased activity of CYP7A1 protein CTD PMID:12700418 CYP7A1 Human manganese(0) increases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Manganese results in increased activity of CYP7A1 protein CTD PMID:12700418 CYP7A1 Human melatonin multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 Melatonin inhibits the reaction [Ethanol results in increased expression of CYP7A1 mRNA] more ... CTD PMID:28095641 CYP7A1 Human melatonin decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Melatonin results in decreased expression of CYP7A1 mRNA CTD PMID:28095641 CYP7A1 Human mercaptoethanol increases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Mercaptoethanol results in increased activity of CYP7A1 protein CTD PMID:1175606 CYP7A1 Human mercury atom decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Mercury results in decreased activity of CYP7A1 protein CTD PMID:1175606 CYP7A1 Human mercury(0) decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Mercury results in decreased activity of CYP7A1 protein CTD PMID:1175606 CYP7A1 Human metacetamol decreases expression ISO Cyp7a1 (Mus musculus) 6480464 3-hydroxyacetanilide results in decreased expression of CYP7A1 mRNA CTD PMID:18544908 CYP7A1 Human metalaxyl decreases expression EXP 6480464 metalaxyl results in decreased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human metformin multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 Metformin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of CYP7A1 mRNA] and Metformin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of CYP7A1 protein] CTD PMID:31100278 CYP7A1 Human metformin increases expression ISO Cyp7a1 (Mus musculus) 6480464 Metformin results in increased expression of CYP7A1 protein CTD PMID:34058177 CYP7A1 Human metformin multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Ethinyl Estradiol co-treated with Metformin] results in decreased expression of CYP7A1 mRNA and [Metformin co-treated with Ethinyl Estradiol] results in decreased expression of CYP7A1 protein CTD PMID:34058177 CYP7A1 Human metformin affects expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Metformin affects the expression of CYP7A1 mRNA CTD PMID:31324951 CYP7A1 Human methapyrilene decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Methapyrilene results in decreased expression of CYP7A1 mRNA CTD PMID:30467583 CYP7A1 Human methotrexate decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Methotrexate results in decreased expression of CYP7A1 mRNA CTD PMID:15120968 CYP7A1 Human methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of CYP7A1 mRNA CTD PMID:24449571 CYP7A1 Human methoxsalen increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Methoxsalen results in increased expression of CYP7A1 protein CTD PMID:28552422 CYP7A1 Human methoxsalen multiple interactions EXP 6480464 Methoxsalen affects the reaction [VDR protein affects the expression of CYP7A1 protein] CTD PMID:30419252 CYP7A1 Human methoxsalen decreases expression EXP 6480464 Methoxsalen results in decreased expression of CYP7A1 protein CTD PMID:30419252 CYP7A1 Human methoxsalen decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Methoxsalen results in decreased expression of CYP7A1 mRNA CTD PMID:28552422 CYP7A1 Human methoxychlor multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of CYP7A1 mRNA CTD PMID:21782745 CYP7A1 Human metronidazole multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] more ... CTD PMID:36464106 and PMID:37211107 CYP7A1 Human monocrotaline multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP7A1 mRNA CTD PMID:21224054 CYP7A1 Human monocrotophos increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Monocrotophos results in increased expression of CYP7A1 mRNA CTD PMID:32267039 CYP7A1 Human monosodium L-glutamate increases expression ISO Cyp7a1 (Mus musculus) 6480464 Sodium Glutamate results in increased expression of CYP7A1 mRNA CTD PMID:19001666 and PMID:20111022 CYP7A1 Human monosodium L-glutamate multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CYP7A1 mRNA CTD PMID:20111022 CYP7A1 Human Muraglitazar increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 muraglitazar results in increased expression of CYP7A1 mRNA CTD PMID:21515302 CYP7A1 Human N-nitrosodiethylamine multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA more ... CTD PMID:17917374 more ... CYP7A1 Human N-nitrosodiethylamine decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Diethylnitrosamine results in decreased expression of CYP7A1 mRNA CTD PMID:19638242 CYP7A1 Human N-nitrosodiethylamine increases expression ISO Cyp7a1 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of CYP7A1 mRNA CTD PMID:18691550 CYP7A1 Human N-nitrosodiethylamine multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:14656948 more ... CYP7A1 Human N-Nitrosopyrrolidine decreases expression EXP 6480464 N-Nitrosopyrrolidine results in decreased expression of CYP7A1 mRNA CTD PMID:32234424 CYP7A1 Human nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of CYP7A1 mRNA CTD PMID:32152650 CYP7A1 Human nefazodone multiple interactions EXP 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA CTD PMID:32152650 CYP7A1 Human neomycin multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] more ... CTD PMID:36464106 and PMID:37211107 CYP7A1 Human nickel atom increases expression ISO Cyp7a1 (Mus musculus) 6480464 Nickel results in increased expression of CYP7A1 mRNA CTD PMID:18922574 CYP7A1 Human nitrofen increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 nitrofen results in increased expression of CYP7A1 mRNA CTD PMID:33484710 CYP7A1 Human O-methyleugenol decreases expression EXP 6480464 methyleugenol results in decreased expression of CYP7A1 mRNA CTD PMID:32234424 CYP7A1 Human obeticholic acid decreases expression ISO Cyp7a1 (Rattus norvegicus) 15045602 obeticholic acid decreases expression of CYP7a1 mRNA in liver in porcine serum induced model of cirrhosis in rat RGD CYP7A1 Human obeticholic acid multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 obeticholic acid inhibits the reaction [Isoniazid results in increased expression of CYP7A1 mRNA] CTD PMID:32673658 CYP7A1 Human obeticholic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein] more ... CTD PMID:29660435 more ... CYP7A1 Human obeticholic acid decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 obeticholic acid results in decreased expression of CYP7A1 mRNA CTD PMID:15644430 and PMID:35267068 CYP7A1 Human obeticholic acid decreases expression EXP 6480464 obeticholic acid results in decreased expression of CYP7A1 mRNA CTD PMID:15911693 and PMID:27939613 CYP7A1 Human obeticholic acid multiple interactions ISO Cyp7a1 (Rattus norvegicus) 15036816 Obeticholic acid inhibits the reaction [ethanol increases expression of Cyp7a1 protein in liver] RGD CYP7A1 Human okadaic acid multiple interactions EXP 6480464 Okadaic Acid promotes the reaction [Calcitriol results in decreased expression of CYP7A1 mRNA] and Okadaic Acid promotes the reaction [lithocholic acid acetate results in decreased expression of CYP7A1 mRNA] CTD PMID:20371703 CYP7A1 Human oleanolic acid decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Oleanolic Acid results in decreased expression of CYP7A1 mRNA and Oleanolic Acid results in decreased expression of CYP7A1 protein CTD PMID:23948738 and PMID:37028458 CYP7A1 Human oleanolic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 GW 4064 inhibits the reaction [Oleanolic Acid results in decreased expression of CYP7A1 mRNA] more ... CTD PMID:37028458 CYP7A1 Human oleic acid decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Oleic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:32738331 CYP7A1 Human oleic acid multiple interactions EXP 6480464 [Oleic Acid co-treated with Palmitic Acid] results in increased expression of CYP7A1 mRNA and Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CYP7A1 mRNA] CTD PMID:38103844 CYP7A1 Human orphenadrine affects expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Orphenadrine affects the expression of CYP7A1 mRNA CTD PMID:23665939 CYP7A1 Human oxybenzone increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 oxybenzone results in increased expression of CYP7A1 mRNA CTD PMID:30316929 CYP7A1 Human p-chloromercuribenzoic acid decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 p-Chloromercuribenzoic Acid results in decreased activity of CYP7A1 protein CTD PMID:1175606 CYP7A1 Human paclitaxel decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Paclitaxel results in decreased expression of CYP7A1 mRNA CTD PMID:15585946 CYP7A1 Human paracetamol affects expression ISO Cyp7a1 (Mus musculus) 6480464 Acetaminophen affects the expression of CYP7A1 mRNA CTD PMID:15030884 and PMID:17562736 CYP7A1 Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CYP7A1 mRNA CTD PMID:36150480 CYP7A1 Human paracetamol multiple interactions EXP 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP7A1 mRNA and kaempferol analog inhibits the reaction [Acetaminophen results in increased expression of CYP7A1 mRNA] CTD PMID:33819548 and PMID:36150480 CYP7A1 Human paracetamol decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of CYP7A1 mRNA CTD PMID:15120968 and PMID:17202762 CYP7A1 Human paracetamol decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Acetaminophen results in decreased expression of CYP7A1 mRNA CTD PMID:18544908 CYP7A1 Human paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of CYP7A1 mRNA CTD PMID:34681664 CYP7A1 Human parathion increases expression ISO Cyp7a1 (Mus musculus) 6480464 Parathion results in increased expression of CYP7A1 mRNA CTD PMID:34813904 CYP7A1 Human pentachlorophenol increases expression ISO Cyp7a1 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of CYP7A1 mRNA CTD PMID:23892564 CYP7A1 Human perflubutane decreases expression ISO Cyp7a1 (Mus musculus) 6480464 perfluorobutane results in decreased expression of CYP7A1 mRNA CTD PMID:23567314 CYP7A1 Human perfluorobutanesulfonic acid increases expression ISO Cyp7a1 (Mus musculus) 6480464 perfluorobutanesulfonic acid results in increased expression of CYP7A1 mRNA CTD PMID:32534104 CYP7A1 Human perfluorobutyric acid increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 perfluorobutyric acid analog results in increased expression of CYP7A1 mRNA CTD PMID:21878386 CYP7A1 Human perfluorodecanoic acid decreases expression EXP 6480464 perfluorodecanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:23567314 CYP7A1 Human perfluorodecanoic acid decreases expression ISO Cyp7a1 (Mus musculus) 6480464 perfluorodecanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:27344344 and PMID:38181850 CYP7A1 Human perfluorodecanoic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 PPARA protein affects the reaction [perfluorodecanoic acid results in decreased expression of CYP7A1 mRNA] CTD PMID:27344344 CYP7A1 Human perfluorodecanoic acid increases expression ISO Cyp7a1 (Mus musculus) 6480464 perfluorodecanoic acid results in increased expression of CYP7A1 mRNA CTD PMID:23567314 CYP7A1 Human perfluorododecanoic acid decreases expression EXP 6480464 perfluorododecanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:23567314 CYP7A1 Human perfluorododecanoic acid decreases expression ISO Cyp7a1 (Mus musculus) 6480464 perfluorododecanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:23567314 CYP7A1 Human perfluoroheptanoic acid increases expression EXP 6480464 perfluoro-n-heptanoic acid results in increased expression of CYP7A1 mRNA CTD PMID:35337807 CYP7A1 Human perfluorohexanesulfonic acid decreases expression ISO Cyp7a1 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of CYP7A1 mRNA CTD PMID:21705711 more ... CYP7A1 Human perfluorohexanesulfonic acid decreases expression EXP 6480464 perfluorohexanesulfonic acid results in decreased expression of CYP7A1 mRNA CTD PMID:23567314 CYP7A1 Human perfluorohexanoic acid decreases expression EXP 6480464 perfluorohexanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:23567314 CYP7A1 Human perfluorononanoic acid decreases expression EXP 6480464 perfluoro-n-nonanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:23567314 and PMID:32588087 CYP7A1 Human perfluorononanoic acid decreases expression ISO Cyp7a1 (Mus musculus) 6480464 perfluoro-n-nonanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:29112762 CYP7A1 Human perfluorononanoic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Dietary Fats co-treated with perfluoro-n-nonanoic acid] results in decreased expression of CYP7A1 mRNA CTD PMID:33483757 CYP7A1 Human perfluorooctane-1-sulfonic acid decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 perfluorooctane sulfonic acid results in decreased expression of CYP7A1 mRNA CTD PMID:16221955 more ... CYP7A1 Human perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of CYP7A1 mRNA CTD PMID:33772556 CYP7A1 Human perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of CYP7A1 mRNA and perfluorooctane sulfonic acid results in decreased expression of CYP7A1 protein CTD PMID:27153767 more ... CYP7A1 Human perfluorooctane-1-sulfonic acid decreases expression ISO Cyp7a1 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in decreased expression of CYP7A1 mRNA CTD PMID:19429403 more ... CYP7A1 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CYP7A1 mRNA and PPARA protein promotes the reaction [perfluorooctane sulfonic acid results in decreased expression of CYP7A1 mRNA] CTD PMID:20936131 and PMID:36331819 CYP7A1 Human perfluorooctanesulfonamide increases expression EXP 6480464 perfluorooctanesulfonamide analog results in increased expression of CYP7A1 mRNA CTD PMID:35337807 CYP7A1 Human perfluorooctanoic acid decreases expression ISO Cyp7a1 (Mus musculus) 6480464 perfluorooctanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:17681415 more ... CYP7A1 Human perfluorooctanoic acid affects expression ISO Cyp7a1 (Mus musculus) 6480464 perfluorooctanoic acid affects the expression of CYP7A1 mRNA CTD PMID:38182912 CYP7A1 Human perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP7A1 mRNA CTD PMID:33772556 CYP7A1 Human perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of CYP7A1 mRNA and perfluorooctanoic acid results in decreased expression of CYP7A1 protein CTD PMID:23567314 more ... CYP7A1 Human perfluorooctanoic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in decreased expression of CYP7A1 mRNA] CTD PMID:20936131 CYP7A1 Human perfluoropentanoic acid increases expression EXP 6480464 perfluoropentanoic acid results in increased expression of CYP7A1 mRNA CTD PMID:35337807 CYP7A1 Human perfluoroundecanoic acid decreases expression EXP 6480464 perfluoroundecanoic acid results in decreased expression of CYP7A1 mRNA CTD PMID:23567314 CYP7A1 Human phenformin decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Phenformin results in decreased expression of CYP7A1 mRNA CTD PMID:31324951 CYP7A1 Human phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of CYP7A1 mRNA CTD PMID:15629111 CYP7A1 Human phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP7A1 mRNA CTD PMID:22258563 CYP7A1 Human phenobarbital multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CYP7A1 mRNA CTD PMID:24535843 CYP7A1 Human phenobarbital decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Phenobarbital results in decreased expression of CYP7A1 mRNA CTD PMID:19162173 CYP7A1 Human phenobarbital decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Phenobarbital results in decreased expression of CYP7A1 mRNA CTD PMID:15629111 CYP7A1 Human phenobarbital increases expression ISO Cyp7a1 (Mus musculus) 6480464 Phenobarbital results in increased expression of CYP7A1 mRNA CTD PMID:19270015 CYP7A1 Human phenytoin multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP7A1 mRNA CTD PMID:21224054 CYP7A1 Human phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CYP7A1 mRNA CTD PMID:16979875 CYP7A1 Human phosphatidylcholine increases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Phosphatidylcholines results in increased activity of CYP7A1 protein CTD PMID:12559476 CYP7A1 Human pioglitazone multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 pioglitazone promotes the reaction [U 0126 results in increased expression of CYP7A1 mRNA] and U 0126 promotes the reaction [pioglitazone results in increased expression of CYP7A1 mRNA] CTD PMID:22593575 CYP7A1 Human pioglitazone increases expression ISO Cyp7a1 (Mus musculus) 6480464 pioglitazone results in increased expression of CYP7A1 mRNA CTD PMID:22593575 CYP7A1 Human pirinixic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 PPARA protein affects the reaction [pirinixic acid results in decreased expression of CYP7A1 mRNA] and PPARA protein promotes the reaction [pirinixic acid results in decreased expression of CYP7A1 mRNA] CTD PMID:15777286 more ... CYP7A1 Human pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CYP7A1 mRNA CTD PMID:31676336 CYP7A1 Human pirinixic acid decreases expression ISO Cyp7a1 (Mus musculus) 6480464 pirinixic acid results in decreased expression of CYP7A1 mRNA CTD PMID:15777286 more ... CYP7A1 Human pirinixic acid increases expression ISO Cyp7a1 (Mus musculus) 6480464 pirinixic acid results in increased expression of CYP7A1 mRNA CTD PMID:20936131 CYP7A1 Human pregnenolone decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Pregnenolone results in decreased activity of CYP7A1 protein CTD PMID:1175606 CYP7A1 Human pregnenolone 16alpha-carbonitrile decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in decreased expression of CYP7A1 mRNA CTD PMID:19162173 CYP7A1 Human pregnenolone 16alpha-carbonitrile decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of CYP7A1 mRNA CTD PMID:15629111 more ... CYP7A1 Human pregnenolone 16alpha-carbonitrile multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in decreased expression of CYP7A1 mRNA] CTD PMID:20359477 CYP7A1 Human prochloraz decreases expression EXP 6480464 prochloraz results in decreased expression of CYP7A1 mRNA CTD PMID:32194361 CYP7A1 Human procymidone affects expression ISO Cyp7a1 (Mus musculus) 6480464 procymidone affects the expression of CYP7A1 mRNA CTD PMID:36764477 CYP7A1 Human propiconazole increases expression ISO Cyp7a1 (Mus musculus) 6480464 propiconazole results in increased expression of CYP7A1 mRNA CTD PMID:21278054 CYP7A1 Human propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of CYP7A1 mRNA CTD PMID:32194361 and PMID:36291160 CYP7A1 Human prothioconazole increases expression ISO Cyp7a1 (Mus musculus) 6480464 prothioconazole results in increased expression of CYP7A1 mRNA CTD PMID:36007749 CYP7A1 Human Prothioconazole-desthio increases expression ISO Cyp7a1 (Mus musculus) 6480464 prothioconazole-desthio results in increased expression of CYP7A1 mRNA CTD PMID:36007749 CYP7A1 Human psoralen decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Ficusin results in decreased expression of CYP7A1 mRNA and Ficusin results in decreased expression of CYP7A1 protein CTD PMID:30597224 CYP7A1 Human puerarin multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 puerarin affects the reaction [Lead affects the expression of CYP7A1] CTD PMID:22001170 CYP7A1 Human PX-866 multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [PX-866 co-treated with SORT1 protein] results in decreased expression of CYP7A1 mRNA CTD PMID:25805502 CYP7A1 Human pyrazinecarboxamide increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Pyrazinamide results in increased expression of CYP7A1 mRNA and Pyrazinamide results in increased expression of CYP7A1 protein CTD PMID:27255380 CYP7A1 Human pyrazinecarboxamide multiple interactions EXP 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of CYP7A1 protein CTD PMID:35835356 CYP7A1 Human pyrazinecarboxamide multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of CYP7A1 protein CTD PMID:35835356 CYP7A1 Human pyrrolidines decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Pyrrolidines analog results in decreased expression of CYP7A1 mRNA CTD PMID:26365562 CYP7A1 Human resveratrol multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Resveratrol results in increased activity of NR1H3 protein] which results in increased expression of CYP7A1 mRNA more ... CTD PMID:22607622 and PMID:31298478 CYP7A1 Human resveratrol increases expression ISO Cyp7a1 (Mus musculus) 6480464 resveratrol results in increased expression of CYP7A1 mRNA CTD PMID:22607622 and PMID:23146569 CYP7A1 Human resveratrol multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] and resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein] CTD PMID:25418378 CYP7A1 Human rifampicin multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP7A1 mRNA CTD PMID:21224054 CYP7A1 Human rifampicin multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of CYP7A1 protein CTD PMID:35835356 CYP7A1 Human rifampicin multiple interactions EXP 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of CYP7A1 protein and NR1I2 protein promotes the reaction [Rifampin results in decreased expression of CYP7A1 mRNA] CTD PMID:21127053 and PMID:35835356 CYP7A1 Human rifampicin decreases expression EXP 6480464 Rifampin results in decreased expression of CYP7A1 mRNA CTD PMID:15629111 more ... CYP7A1 Human rifaximin multiple interactions EXP 6480464 [NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of CYP7A1 protein CTD PMID:22790967 CYP7A1 Human ritonavir decreases expression EXP 6480464 Ritonavir results in decreased expression of CYP7A1 mRNA CTD PMID:26626330 CYP7A1 Human ritonavir decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Ritonavir results in decreased expression of CYP7A1 mRNA CTD PMID:17719200 CYP7A1 Human rotenone affects expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Rotenone affects the expression of CYP7A1 mRNA CTD PMID:28374803 CYP7A1 Human S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 [S-(1 more ... CTD PMID:35811015 CYP7A1 Human Salidroside multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 rhodioloside inhibits the reaction [furan results in decreased expression of CYP7A1 mRNA] CTD PMID:32251705 CYP7A1 Human saracatinib increases expression EXP 6480464 saracatinib results in increased expression of CYP7A1 mRNA CTD PMID:20371703 CYP7A1 Human saracatinib multiple interactions EXP 6480464 saracatinib inhibits the reaction [Calcitriol results in decreased expression of CYP7A1 mRNA] more ... CTD PMID:20371703 CYP7A1 Human selenium atom multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Magnesium co-treated with Selenium co-treated with Dietary Fats] results in increased expression of CYP7A1 mRNA CTD PMID:30031400 CYP7A1 Human selenium atom multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] CTD PMID:36464106 CYP7A1 Human senecionine decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 senecionine results in decreased expression of CYP7A1 mRNA CTD PMID:24641316 CYP7A1 Human senecionine decreases expression ISO Cyp7a1 (Mus musculus) 6480464 senecionine results in decreased expression of CYP7A1 mRNA CTD PMID:31606820 CYP7A1 Human senecionine decreases expression EXP 6480464 senecionine results in decreased expression of CYP7A1 mRNA CTD PMID:26100227 CYP7A1 Human Senkirkine decreases expression EXP 6480464 senkirkine results in decreased expression of CYP7A1 mRNA CTD PMID:26100227 CYP7A1 Human sevoflurane affects expression ISO Cyp7a1 (Rattus norvegicus) 6480464 sevoflurane affects the expression of CYP7A1 mRNA CTD PMID:15967596 CYP7A1 Human simvastatin multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 Simvastatin promotes the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA] and Simvastatin promotes the reaction [Dietary Fats results in increased expression of CYP7A1 protein] CTD PMID:33383043 CYP7A1 Human sodium arsenite decreases expression ISO Cyp7a1 (Mus musculus) 6480464 sodium arsenite results in decreased expression of CYP7A1 mRNA and sodium arsenite results in decreased expression of CYP7A1 protein CTD PMID:31532247 more ... CYP7A1 Human sodium arsenite multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 NR1H3 protein promotes the reaction [sodium arsenite results in decreased expression of CYP7A1 protein] and salvin inhibits the reaction [sodium arsenite results in decreased expression of CYP7A1 mRNA] CTD PMID:35202923 and PMID:37668303 CYP7A1 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CYP7A1 mRNA CTD PMID:29301061 CYP7A1 Human sodium cholate multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Sodium Cholate co-treated with Dietary Fats] results in decreased expression of CYP7A1 mRNA CTD PMID:23665937 CYP7A1 Human sodium dichromate increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 sodium bichromate results in increased expression of CYP7A1 mRNA CTD PMID:12325037 CYP7A1 Human soybean oil increases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Soybean Oil results in increased activity of CYP7A1 protein CTD PMID:12559476 CYP7A1 Human spironolactone decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Spironolactone results in decreased activity of CYP7A1 protein CTD PMID:15652244 CYP7A1 Human streptozocin increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Streptozocin results in increased expression of CYP7A1 mRNA CTD PMID:10393316 CYP7A1 Human streptozocin increases expression ISO Cyp7a1 (Mus musculus) 6480464 Streptozocin results in increased expression of CYP7A1 mRNA CTD PMID:34896238 CYP7A1 Human streptozocin multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Dietary Fats co-treated with Streptozocin] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:29382564 and PMID:34896238 CYP7A1 Human streptozocin multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Dietary Fats co-treated with Streptozocin] results in decreased expression of CYP7A1 mRNA more ... CTD PMID:31100278 CYP7A1 Human sulfluramid increases expression EXP 6480464 sulfluramid results in increased expression of CYP7A1 mRNA CTD PMID:35337807 CYP7A1 Human sulforaphane decreases expression EXP 6480464 sulforaphane results in decreased expression of CYP7A1 mRNA CTD PMID:34767876 CYP7A1 Human Sunset Yellow FCF multiple interactions EXP 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP7A1 mRNA CTD PMID:33819548 CYP7A1 Human tamoxifen decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Tamoxifen results in decreased expression of CYP7A1 mRNA CTD PMID:19224547 CYP7A1 Human tamoxifen affects expression ISO Cyp7a1 (Mus musculus) 6480464 Tamoxifen affects the expression of CYP7A1 mRNA CTD PMID:20937368 CYP7A1 Human tartrazine multiple interactions EXP 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP7A1 mRNA CTD PMID:33819548 CYP7A1 Human taurocholic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 FGFR4 protein affects the reaction [Taurocholic Acid results in decreased expression of CYP7A1 mRNA] and NR1H4 protein affects the reaction [Taurocholic Acid results in decreased expression of CYP7A1 mRNA] CTD PMID:16284190 CYP7A1 Human taurocholic acid decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Taurocholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:7832767 CYP7A1 Human taurocholic acid decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Taurocholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:16284190 CYP7A1 Human tauroursodeoxycholic acid multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 ursodoxicoltaurine inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein] CTD PMID:36787806 CYP7A1 Human tebuconazole decreases expression EXP 6480464 tebuconazole results in decreased expression of CYP7A1 mRNA CTD PMID:30458266 more ... CYP7A1 Human tectorigenin multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 tectorigenin inhibits the reaction [Dietary Fats results in decreased expression of CYP7A1 mRNA] and tectorigenin inhibits the reaction [Dietary Fats results in decreased expression of CYP7A1 protein] CTD PMID:35390440 CYP7A1 Human Tesaglitazar decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 tesaglitazar results in decreased expression of CYP7A1 mRNA CTD PMID:21515302 CYP7A1 Human testosterone decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Testosterone results in decreased expression of CYP7A1 mRNA CTD PMID:21669218 CYP7A1 Human tetrachloromethane decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of CYP7A1 mRNA CTD PMID:19224547 and PMID:31150632 CYP7A1 Human tetrachloromethane multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 alisol B 23-acetate promotes the reaction [Carbon Tetrachloride results in decreased expression of CYP7A1 mRNA] and Chenodeoxycholic Acid promotes the reaction [Carbon Tetrachloride results in decreased expression of CYP7A1 mRNA] CTD PMID:25747392 CYP7A1 Human tetrachloromethane increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of CYP7A1 mRNA CTD PMID:30723492 CYP7A1 Human tetrachloromethane increases expression ISO Cyp7a1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of CYP7A1 mRNA CTD PMID:29987408 CYP7A1 Human tetrachloromethane multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 1 more ... CTD PMID:31150632 and PMID:35872049 CYP7A1 Human tetrachloromethane decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of CYP7A1 mRNA CTD PMID:25747392 more ... CYP7A1 Human tetracycline increases expression ISO Cyp7a1 (Mus musculus) 6480464 Tetracycline results in increased expression of CYP7A1 mRNA CTD PMID:16917069 CYP7A1 Human tetracycline decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Tetracycline results in decreased expression of CYP7A1 mRNA CTD PMID:19224547 CYP7A1 Human Theaflavin 3,3'-digallate affects expression EXP 6480464 theaflavin-3 and 3'-digallate affects the expression of CYP7A1 mRNA CTD PMID:34925699 CYP7A1 Human thiacloprid decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 thiacloprid results in decreased expression of CYP7A1 mRNA CTD PMID:33426623 CYP7A1 Human thiacloprid decreases expression EXP 6480464 thiacloprid results in decreased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human thiacloprid multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [thiacloprid co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA and [thiacloprid co-treated with enilconazole] results in decreased expression of CYP7A1 mRNA CTD PMID:33426623 CYP7A1 Human thiamethoxam decreases expression EXP 6480464 Thiamethoxam results in decreased expression of CYP7A1 protein CTD PMID:32194361 CYP7A1 Human thioacetamide increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of CYP7A1 mRNA CTD PMID:26222700 CYP7A1 Human thioacetamide decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of CYP7A1 mRNA CTD PMID:34492290 CYP7A1 Human thiram decreases expression EXP 6480464 Thiram results in decreased expression of CYP7A1 mRNA CTD PMID:32194361 CYP7A1 Human titanium dioxide multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 Resveratrol promotes the reaction [titanium dioxide results in decreased expression of CYP7A1 mRNA] CTD PMID:31298478 CYP7A1 Human titanium dioxide decreases expression ISO Cyp7a1 (Mus musculus) 6480464 titanium dioxide results in decreased expression of CYP7A1 mRNA CTD PMID:31298478 CYP7A1 Human toluene affects expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Toluene affects the expression of CYP7A1 mRNA CTD PMID:18653662 CYP7A1 Human tributylstannane increases expression ISO Cyp7a1 (Mus musculus) 6480464 tributyltin results in increased expression of CYP7A1 mRNA CTD PMID:31939706 CYP7A1 Human Tributyltin oxide decreases expression ISO Cyp7a1 (Mus musculus) 6480464 bis(tri-n-butyltin)oxide results in decreased expression of CYP7A1 mRNA CTD PMID:18958704 CYP7A1 Human trichloroethene increases expression ISO Cyp7a1 (Mus musculus) 6480464 Trichloroethylene results in increased expression of CYP7A1 mRNA CTD PMID:19254012 CYP7A1 Human trichloroethene decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Trichloroethylene results in decreased expression of CYP7A1 mRNA CTD PMID:33387578 CYP7A1 Human trichloroethene increases methylation ISO Cyp7a1 (Rattus norvegicus) 6480464 Trichloroethylene results in increased methylation of CYP7A1 gene CTD PMID:27618143 CYP7A1 Human trichloroethene decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Trichloroethylene results in decreased expression of CYP7A1 mRNA CTD PMID:25549359 CYP7A1 Human triclosan multiple interactions EXP 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in decreased expression of CYP7A1 mRNA CTD PMID:33819548 CYP7A1 Human triclosan affects expression EXP 6480464 Triclosan affects the expression of CYP7A1 mRNA CTD PMID:34681664 CYP7A1 Human triphenyl phosphate increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 triphenyl phosphate results in increased expression of CYP7A1 mRNA CTD PMID:30589522 CYP7A1 Human triphenyl phosphate affects expression ISO Cyp7a1 (Mus musculus) 6480464 triphenyl phosphate affects the expression of CYP7A1 mRNA CTD PMID:36563926 CYP7A1 Human Triptolide multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [triptolide co-treated with Lipopolysaccharides] results in decreased expression of CYP7A1 protein more ... CTD PMID:32987112 and PMID:36328986 CYP7A1 Human Triptolide decreases expression ISO Cyp7a1 (Mus musculus) 6480464 triptolide results in decreased expression of CYP7A1 mRNA CTD PMID:32987112 CYP7A1 Human tris(2-butoxyethyl) phosphate decreases expression EXP 6480464 tris(2-butoxyethyl) phosphate results in decreased expression of CYP7A1 mRNA CTD PMID:29024780 CYP7A1 Human tris(2-chloroethyl) phosphate multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of CYP7A1 mRNA] CTD PMID:35780845 CYP7A1 Human tris(2-chloroethyl) phosphate decreases expression ISO Cyp7a1 (Mus musculus) 6480464 tris(chloroethyl)phosphate results in decreased expression of CYP7A1 mRNA CTD PMID:35780845 CYP7A1 Human troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of CYP7A1 mRNA CTD PMID:19631733 CYP7A1 Human troglitazone increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 troglitazone results in increased expression of CYP7A1 mRNA CTD PMID:21515302 CYP7A1 Human trovafloxacin multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [trovafloxacin co-treated with lipopolysaccharide and E coli O55-B5] results in decreased expression of CYP7A1 mRNA CTD PMID:18930950 CYP7A1 Human urethane decreases expression EXP 6480464 Urethane results in decreased expression of CYP7A1 mRNA CTD PMID:28818685 CYP7A1 Human ursodeoxycholic acid multiple interactions ISO Cyp7a1 (Rattus norvegicus) 6480464 [Tretinoin co-treated with Ursodeoxycholic Acid] results in decreased expression of CYP7A1 mRNA and Ursodeoxycholic Acid inhibits the reaction [Ethinyl Estradiol results in decreased expression of CYP7A1 mRNA] CTD PMID:16487557 and PMID:21274875 CYP7A1 Human ursodeoxycholic acid decreases expression ISO Cyp7a1 (Mus musculus) 6480464 Ursodeoxycholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:20671298 and PMID:25582706 CYP7A1 Human ursodeoxycholic acid decreases expression EXP 6480464 Ursodeoxycholic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:14684751 and PMID:21274875 CYP7A1 Human ursodeoxycholic acid increases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 Ursodeoxycholic Acid results in increased expression of CYP7A1 mRNA CTD PMID:16764892 CYP7A1 Human ursodeoxycholic acid multiple interactions EXP 6480464 Tretinoin promotes the reaction [Ursodeoxycholic Acid results in decreased expression of CYP7A1 mRNA] and Ursodeoxycholic Acid promotes the reaction [Tretinoin results in decreased expression of CYP7A1 mRNA] CTD PMID:21274875 CYP7A1 Human usnic acid multiple interactions EXP 6480464 [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CYP7A1 mRNA CTD PMID:22777745 CYP7A1 Human valdecoxib decreases expression ISO Cyp7a1 (Rattus norvegicus) 6480464 valdecoxib results in decreased expression of CYP7A1 mRNA CTD PMID:24136188 CYP7A1 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:29154799 and PMID:29501571 CYP7A1 Human vancomycin multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] more ... CTD PMID:24657338 more ... CYP7A1 Human Yangonin multiple interactions ISO Cyp7a1 (Mus musculus) 6480464 NR1H4 promotes the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]] more ... CTD PMID:29660435 CYP7A1 Human Yangonin decreases expression ISO Cyp7a1 (Mus musculus) 6480464 yangonin results in decreased expression of CYP7A1 mRNA CTD PMID:29660435 CYP7A1 Human zinc atom multiple interactions EXP 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CYP7A1 mRNA CTD PMID:16979875 CYP7A1 Human zinc atom decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Zinc results in decreased activity of CYP7A1 protein CTD PMID:1175606 CYP7A1 Human zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of CYP7A1 mRNA CTD PMID:18356318 CYP7A1 Human zinc pyrithione increases expression EXP 6480464 pyrithione zinc results in increased expression of CYP7A1 mRNA CTD PMID:21424779 CYP7A1 Human zinc(0) multiple interactions EXP 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CYP7A1 mRNA CTD PMID:16979875 CYP7A1 Human zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of CYP7A1 mRNA CTD PMID:18356318 CYP7A1 Human zinc(0) decreases activity ISO Cyp7a1 (Rattus norvegicus) 6480464 Zinc results in decreased activity of CYP7A1 protein CTD PMID:1175606